Patients with non-small-cell lung cancer harbouring a BRAF mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14

BACKGROUND: Mutations in BRAF are rare oncogene mutations, found in 2% of non-small-cell lung cancers (nsclcs). Little information is available about the management of patients with BRAF-mutated nsclc, except for those included in clinical trials. We undertook the present study to assess the clinica...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Curr Oncol
Hlavní autoři: Auliac, J.B., Bayle, S., Vergnenegre, A., Le Caer, H., Falchero, L., Gervais, R., Doubre, H., Vinas, F., Marin, B., Chouaid, C.
Médium: Artigo
Jazyk:Inglês
Vydáno: Multimed Inc. 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6209546/
https://ncbi.nlm.nih.gov/pubmed/30464690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.25.3945
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky